Midwest Veterans' Biomedical Research Foundation

Midwest Veterans Biomedical Research Foundation is a non-profit, tax-exempt corporate entity registered in SAM.gov since 2006, located in Kansas City, Missouri. The organization specializes in medical research, particularly focusing on advanced biomedical studies involving complex disease mechanisms, clinical decision support tools, and innovative research methodologies. While specific details about its organizational mission are not explicitly provided, the foundation appears dedicated to conducting high-level scientific research that addresses critical medical challenges, with a particular emphasis on veteran health and advanced medical investigations.

The foundation has received significant federal grant awards demonstrating expertise across multiple research domains. Most recently, the Defense Health Agency awarded a $1,209,369 project grant to investigate the SH3BP2 protein's role in nephrotic syndrome immunopathogenesis, spanning from 2024 to 2028. Previous federal grant sub-awards reveal diverse research capabilities, including developing machine learning-based clinical decision support tools for COVID-19 patient management, conducting cancer research through the SWOG NCORP Research Base, and performing intricate laboratory studies on kidney disease using mouse models. The foundation has collaborated with prestigious research institutions like the University of Kansas Medical Center Research Institute, University of Wisconsin System, and Oregon Health & Science University. Their research typically involves complex experimental designs, molecular biology techniques, data interpretation, and developing innovative medical technologies, with a strong focus on translational research that bridges laboratory findings to potential clinical applications.